Bert J. E. G. Bast - Concepedia

Author

Bert J. E. G. Bast

Utrecht University

Also Known As

B J Bast, B J E G Bast, B. J. E. G. Bast, BERT J.E.G. BAST, Bert J. E. G. Bast, Bert J.E.G Bast, Bert J.E.G. Bast

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Utrecht University University Medical Center Utrecht University of Cambridge Dutch Blood Transfusion Society Hubrecht Institute for Developmental Biology and Stem Cell Research

About

Bert J. E. G. Bast is an author at Utrecht University specializing in medicine, immunotherapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	730
2	Cell Biology	9	9	336
3	Allergy	2	2	155
4	Health Sciences	1	1	33
5	Biology	1	1	38

Bert J. E. G. Bast

Publications

Citations

H-Index

Page 1

	Year	Citations
IgE to Bet v 1 and profilin: Cross-reactivity patterns and clinical relevance Jaap H. Akkerdaas, W.A. van Leeuwen, Steven O. Stapel, Journal of Allergy and Clinical Immunology Bet V 1Clinical EvidenceClinical RelevanceEvidence-based MedicineClinical Review	2002	206
The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase. Bert J. E. G. Bast, Libo Zhou, Gordon J. Freeman, The Journal of Cell Biology Cd76 Differentiation AntigensLaboratory ImmunologyGlycobiologyImmunologyImmunodominance	1992	118
Clinical Experience with CD3 X CD19 Bispecific Antibodies in Patients with B Cell Malignancies G C de Gast, Anja A. van Houten, Inez-Anne Haagen, Journal of Hematotherapy	1995	69
The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of <i>MAFB</i>: a molecular and genetic analysis of the chromosomal breakpoint Gienke R. Boersma‐Vreugdenhil, Jeroen Kuipers, Esther van Stralen, British Journal of Haematology	2004	54
Identification of primary MAFB target genes in multiple myeloma Esther van Stralen, Marc van de Wetering, Luca Agnelli, Experimental Hematology Hematological MalignancyPathologyMultiple MyelomaMedicineCancer Research	2008	54
Absence of preferential homologous H/L chain association in hybrid hybridomas Wilma Lau, K Heije, Jacques Neefjes, The Journal of Immunology	1991	48
CD8 T cell activation after intravenous administration of CD3×CD19 bispecific antibody in patients with non-Hodgkin lymphoma Gijsbert C. de Gast, Inez-Anne Haagen, Anja A. van Houten, Cancer Immunology Immunotherapy Lymphoid NeoplasiaCd3×cd19 Bispecific AntibodyCancer ImmunosurveillanceIntravenous AdministrationImmunology	1995	47
Fluorescence In Situ Hybridization Analysis Shows the Frequent Occurrence of 14q32.3 Rearrangements with Involvement of Immunoglobulin Switch Regions in Myeloma Cell Lines Jeroen Kuipers, Jan Willem Vaandrager, Danielle Olde Weghuis, Cancer Genetics and Cytogenetics Hematological MalignancyImmunocytochemical TechniqueMalignant Blood DisorderHematologyImmunology	1999	47
Production of hybrid hybridomas based on HATs-neomycinr double mutants Wim B. M. de Lau, AndréE. van Loon, K Heije, Journal of Immunological Methods BiologyHybridisationHybridizationGeneticsHybrid Hybridomas	1989	38
Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67 Henk M. Lokhorst, Saskia E. Boom, Wim Terpstra, British Journal of Haematology Human GrowthImmunologyPathologyImmunophenotypingGrowth Fraction	1988	38

Page 1